欢迎来到天天文库
浏览记录
ID:54982790
大小:243.59 KB
页数:3页
时间:2020-05-07
《抗病毒治疗对HBeAg阴性慢性乙型肝炎患者外周血T淋巴细胞亚群状态的影响-论文.pdf》由会员上传分享,免费在线阅读,更多相关内容在应用文档-天天文库。
1、检验医学与临床2014年3月第11卷第5期LabMedClin,March2O14,Vo1.11,No.5·595··论著·抗病毒治疗对HBeAg阴性慢性乙型肝炎患者外周血T淋巴细胞亚群状态的影响刘小琴(重庆市垫江县人民医院感染科408300)【摘要】目的探讨抗病毒治疗对乙型肝炎e抗原(HBeAg)阴性慢性乙型肝炎(CHB)患者外周血T淋巴细胞亚群状态的影响。方法选择重庆市垫江县人民医院就诊的7O例HBeAg阴性CHB患者为试验组,采用流式细胞技术检测研究对象外周血CD4、CD8T淋巴细胞的表达情况,并在抗病毒治疗24周后,再次检测CD4、CD8T淋巴细胞、HBV-DNA的表达及
2、肝功能变化情况。并与同期门诊正常体检健康者35例(对照组)检测结果作对照研究。结果实验组CD4。。T淋巴细胞较对照组降低,而CD8。。则相对较高,差异有统计学意义(P3、sn.1672-9455.2014.05.007文献标志码:A文章编号:1672—9455(2014)05—0595—02Theeffectsofanti-hepatitisBvirustreatmentonthevariationsofT-lymphocytesubsetsinperipheralbloodofHBeAg-negativechronichepatitisBpatientsLIUXiao—qin(DepartmentofInfections,PeopleHospitalofDianJiang。Chongqing408300,China)[Abstract]Obje4、ctiveToinvestigatethevariationofTlymphocytesubsetsinperipheralbloodofpatientswithHBeAg—negativechronichepatitisBafterthetreatmentofLamivudine.MethodsFolwcytometrywasusedtodetecttheCD4。CD8Tcell,liverfunctionandHBV—DNAin70patientswithHBeAg—negativechronichepatitisB.Theseindicatorsweredetectedag5、ainafter24weekstherapyofLamivudine.ResultsThepercentageofCD4Tcellwaslower,buthigherinCD8Tcells,andbothhadstatisticaldifferencescomparedwithcontrols(P<0.05).AftertheantiviraltherapybyIamivudinefor24weeks,theexpressionofHBV-DNA,ALTandASTsignificantlydegradedandtheclinicalsymptomsalsoimproved。fu6、rthermoretheexpressionofCD4Tcellobviouslyincreased(P%0.05).Con—clusionT-lymphocytepalyedextremelyimportantroleinthecourseofdiseasewithHBeAg-negativechronichepati—tisBpatientsandanti—hepatitisBvirustreatmentcouldenhancecellularimmunityofthepatients,andimprovetheex—pressionofT-lymphocytesubsets7、.[Keywords]chronichepatitisB;T—lymphocytesubsets;lamivudine近年来乙型肝炎病毒(HBV)感染成为全球一个较为严重南(2010年版)诊断标准,所选患者诊断均符合HBeAg阴性的公共卫生问题,由于HBV免疫疫苗的广泛使用及各种抗病HBV。将HBeAg阴性患者依据肝功能情况分为轻、中、重度毒药物的临床应用,导致HBV变异株的出现,HBVe抗原三组。对照组为门诊正常体检健康者35例,其中男2O例,女(HBeAg)阴性的慢性乙型肝炎
3、sn.1672-9455.2014.05.007文献标志码:A文章编号:1672—9455(2014)05—0595—02Theeffectsofanti-hepatitisBvirustreatmentonthevariationsofT-lymphocytesubsetsinperipheralbloodofHBeAg-negativechronichepatitisBpatientsLIUXiao—qin(DepartmentofInfections,PeopleHospitalofDianJiang。Chongqing408300,China)[Abstract]Obje
4、ctiveToinvestigatethevariationofTlymphocytesubsetsinperipheralbloodofpatientswithHBeAg—negativechronichepatitisBafterthetreatmentofLamivudine.MethodsFolwcytometrywasusedtodetecttheCD4。CD8Tcell,liverfunctionandHBV—DNAin70patientswithHBeAg—negativechronichepatitisB.Theseindicatorsweredetectedag
5、ainafter24weekstherapyofLamivudine.ResultsThepercentageofCD4Tcellwaslower,buthigherinCD8Tcells,andbothhadstatisticaldifferencescomparedwithcontrols(P<0.05).AftertheantiviraltherapybyIamivudinefor24weeks,theexpressionofHBV-DNA,ALTandASTsignificantlydegradedandtheclinicalsymptomsalsoimproved。fu
6、rthermoretheexpressionofCD4Tcellobviouslyincreased(P%0.05).Con—clusionT-lymphocytepalyedextremelyimportantroleinthecourseofdiseasewithHBeAg-negativechronichepati—tisBpatientsandanti—hepatitisBvirustreatmentcouldenhancecellularimmunityofthepatients,andimprovetheex—pressionofT-lymphocytesubsets
7、.[Keywords]chronichepatitisB;T—lymphocytesubsets;lamivudine近年来乙型肝炎病毒(HBV)感染成为全球一个较为严重南(2010年版)诊断标准,所选患者诊断均符合HBeAg阴性的公共卫生问题,由于HBV免疫疫苗的广泛使用及各种抗病HBV。将HBeAg阴性患者依据肝功能情况分为轻、中、重度毒药物的临床应用,导致HBV变异株的出现,HBVe抗原三组。对照组为门诊正常体检健康者35例,其中男2O例,女(HBeAg)阴性的慢性乙型肝炎
此文档下载收益归作者所有